Medis Consulting conducted a Systematic Literature Review (SLR) to document the evidence base linking hospital design elements on patient outcomes for a large global engineering firm.

Medis Consulting conducted an online survey in the US, Europe, and LATAM to quantify the value of various clinical profiles for an novel therapy in development for an ultra-orphan CNS indication.

A mid-sized pharmaceutical company with a leading second generation antihistamine knew they were not maximizing their Direct to Consumer (DTC) impact in the US.  We repositioned the brand with patients and led to more compelling messages and increased sales.

A manufacturer of primarily generic products had made an advancement in the formulation of a standard hospital antibiotic.  They wanted to bring two novel formulations to market and asked us to provide insights on the likely use and appropriate pricing of each formulation.

A leading pharmaceutical company had a unique challenge.  One of their old respiratory products continued to sell well long after they stopped supporting it.  We helped them understand who was using the product and why, and how they could cost effectively build their revenues further.

A large pharmaceutical client with a significant respiratory portfolio was interested in better partnering with experts in US health systems.  They ask us to find a representative group of in-house experts and identify opportunities, drivers, and barriers to partnership.

A large pharmaceutical company needed to reorganize their US hospital sales force to better address the changing dynamics of hospital systems.  We gathered insights in three pilot markets to improve their sales approach to better reflect the interests of their organized clients.

A large pharmaceutical client was bringing an immuno-oncology franchise to market with very high expectations.  We worked with them to create positioning and branding for the entire franchise that was informative, compelling, and coordinated with the brand positioning of their leading compounds.

A professional and consumer nutritional company sought new opportunities for nutritional supplementation.  They identified COPD as an area of unmet need, but knew little about the disease and its treatment.  We mapped the patient pathway and facilitated two top level workshops to identify opportunities for them to pursue.

A large medtech company wanted to improve the effectiveness of a common orthopedic procedure in order to better position their products with payers.  We mapped out the patient pathway for the procedure and highlighted areas where they could partner with payers, patients, and providers to add value.